Chromocell Therapeutics Corp - COM SHS (CHRO)

Historical Portfolio Holders from Q1 2024 to Q2 2024

All holders as of June 30, 2024: Q2 2024
Type / Class: Equity / COM SHS
Shares, excl. options Q2 2024: 220K
Holdings value Q2 2024: $290K
Value change Q2 2024: -$42.2K
Grand Portfolio weight change Q2 2024: 0%
Number of holders: 5
Number of buys Q2 2024: 4
Number of sells Q2 2024: -1
Average buys Q2 2024 %: 0%
Average sells Q2 2024 %: 0%

Reported Shares, Excluding Options vs Price

Reported Value, Excluding Options

Total Investors

Period	Shares, Excl. Options	Value, Excl. Options	Change	Puts Notional Value	Calls Notional Value	Price	Investors
2024 Q2	220K	$290K	-$42.2K			$1.32	5
2024 Q1	252K	$660K	+$660K			$2.62	1